1. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. (September 2015) Authors: Chau, I.; Park, J.O.; Ryoo, B.Y.; Yen, C.J.; Poon, R.; Pastorelli, D.; Blanc, J.F.; Kudo, M.; Pfiffer, T.F.; Hatano, E.; Chung, H.C.; Kubackova, K.; Phelip, J.M.; Brandi, G.; Ohkawa, S.; Li, C.P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1134: OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA POST-CBTK INHIBITOR THERAPY IN THE UNITED STATES AND JAPAN: A STUDY OF TWO REAL-WORLD DATABASES. (23rd June 2022) Authors: Rai, S.; Hess, L.; Chen, Y.; Abada, P.; Konig, H.; Walgren, R.; Tanizawa, Y.; Cai, Z.; Tajimi, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P639: OUTCOMES FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA PREVIOUSLY TREATED WITH A COVALENT BTK AND BCL2 INHIBITOR IN THE UNITED STATES: A REAL-WORLD DATABASE STUDY. (23rd June 2022) Authors: Mato, A. R.; Chen, Y.; Girvan, A. C.; Hess, L. M.; Bowman, L.; Abada, P.; Konig, H.; Walgren, R. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗